Laura Roth

High prevalence of MAP2K1 mutations in variant and IGHV4-34–expressing hairy-cell leukemias

Joshua J. Waterfall, Evgeny Arons, Robert L. Walker et al. · Nature Genetics · 2013 · 270 citations · Full text

Hematological Malignancy, Ighv4-34–expressing Hairy-cell Leukemias, Medicine +9

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

Nicole Mayer-Hamblett, Félix Ratjen, Renee Russell et al. · The Lancet Respiratory Medicine · 2022 · 116 citations · Full text

Medicine, Hypertonic Saline, Dornase Alfa +1

Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial

Félix Ratjen, Stephanie D. Davis, Sanja Stanojevic et al. · The Lancet Respiratory Medicine · 2019 · 111 citations

Pediatrics, Pediatric Lung Disease, Placebo-controlled Trial +3

Cladribine with Immediate Rituximab for the Treatment of Patients with Variant Hairy Cell Leukemia

Robert J. Kreitman, Wyndham H. Wilson, Katherine R. Calvo et al. · Clinical Cancer Research · 2013 · 68 citations

Evidence of canonical somatic hypermutation in hairy cell leukemia

Evgeny Arons, Laura Roth, Jeffrey Sapolsky et al. · Blood · 2011 · 39 citations · Full text